Glypican-3: Comparison of a novel stain in immunocytochemistry and immunohistochemistry in hepatocellular carcinoma

被引：0
作者：
Kandil, D.
Leiman, G.
Trotman, W.
Allegretta, M.
Pantanowitz, L.
Goulart, R.
Evans, M.
机构：
[1] Univ Vermont, Burlington, VT USA
[2] Baystate Med Ctr, Springfield, MA USA
来源：
ACTA CYTOLOGICA | 2007年 / 51卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：331 / 331
页数：1
相关论文
共 50 条
[31]   Usefulness of the Novel Oncofetal Antigen Glypican-3 for Diagnosis of Hepatocellular Carcinoma and Melanoma [J].
Tetsuya Nakatsura ;
Yasuharu Nishimura .
BioDrugs, 2005, 19 :71-77
[32]   NOVEL PEPTIDE BINDER TO GLYPICAN-3 FOR TARGETED RADIOPHARMACEUTICAL THERAPY OF HEPATOCELLULAR CARCINOMA [J].
Song, Ken .
INTERNAL MEDICINE JOURNAL, 2023, 53 :10-10
[33]   Novel peptide binder to Glypican-3 for targeted radiopharmaceutical therapy of hepatocellular carcinoma [J].
Li, Gary ;
Lin, Fanching ;
Clift, Renee ;
Ehara, Takeru ;
Yanagida, Hayato ;
Horton, Steven ;
Salvador, Katrina ;
Richardson, Samantha ;
Guest, Matt ;
Noncovich, Alain ;
Bhat, Abhijit ;
Han, Guangzhou .
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[34]   Glypican-3 immunocytochemistry in liver fine needle aspirates: A novel stain to assist in differentiation of benign and malignant liver lesions [J].
Kandil, D. ;
Leiman, G. ;
Trotman, W. ;
Allegretta, M. ;
Pantanowitz, L. ;
Goulart, R. ;
Evans, M. .
MODERN PATHOLOGY, 2007, 20 :73A-73A
[35]   Glypican-3 immunocytochemistry in liver fine needle aspirates: A novel stain to assist in differentiation of benign and malignant liver lesions [J].
Kandil, D. ;
Leiman, G. ;
Trotman, W. ;
Allegretta, M. ;
Pantanowitz, L. ;
Goulart, R. ;
Evans, M. .
LABORATORY INVESTIGATION, 2007, 87 :73A-73A
[36]   Identification of microRNAs controlling Glypican-3 expression in hepatocellular carcinoma [J].
Maurel, M. ;
Ladeiro, Y. ;
Jalvy-Delvaille, S. ;
Pitard, V. ;
Vachet, L. ;
Combe, C. ;
Sagliocco, F. ;
Zucman-Rossi, I. ;
Laloo, B. ;
Grosset, C. .
BULLETIN DU CANCER, 2011, 98 :S43-S44
[37]   Peptide Binder to Glypican-3 as a Theranostic Agent for Hepatocellular Carcinoma [J].
Lin, Fanching ;
Clift, Renee ;
Ehara, Takeru ;
Yanagida, Hayato ;
Horton, Steven ;
Noncovich, Alain ;
Guest, Matt ;
Kim, Daniel ;
Salvador, Katrina ;
Richardson, Samantha ;
Miller, Terra ;
Han, Guangzhou ;
Bhat, Abhijit ;
Song, Kenneth ;
Li, Gary .
JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (04) :586-592
[38]   Role of glypican-3 immunocytochemistry in differentiating hepatocellular carcinoma from metastatic carcinoma of the liver utilizing fine needle aspiration cytology [J].
Zaakook, Mohamed ;
Ayoub, Menar ;
Abu Sinna, Eman ;
El-Sheikh, Samar .
JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2013, 25 (04) :173-180
[39]   Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinoma [J].
Kaseb, Ahmed Omar ;
Hassan, Manal ;
Lacin, Sahin ;
Abdel-Wahab, Reham ;
Amin, Hesham M. ;
Shalaby, Ahmed ;
Wolff, Robert A. ;
Yao, James ;
Rashid, Asif ;
Vennapusa, Bharathi ;
Feng, Janine ;
Ohtomo, Toshihiko .
ONCOTARGET, 2016, 7 (43) :69916-69926
[40]   ImmunoPET as Stoichiometric Sensor for Glypican-3 in Models of Hepatocellular Carcinoma [J].
Kelada, O. J. ;
Gutsche, N. T. ;
Bell, M. ;
Berman, R. M. ;
Baidoo, K. E. ;
Warner, B. M. ;
Szajek, L. P. ;
Hong, J. ;
Ho, M. ;
Choyke, P. ;
Escorcia, F. E. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03) :S180-S181
12345